[go: up one dir, main page]

AP2009004747A0 - Compounds having a potentiating effect on the activity of ethoionamide and uses thereof - Google Patents

Compounds having a potentiating effect on the activity of ethoionamide and uses thereof

Info

Publication number
AP2009004747A0
AP2009004747A0 AP2009004747A AP2009004747A AP2009004747A0 AP 2009004747 A0 AP2009004747 A0 AP 2009004747A0 AP 2009004747 A AP2009004747 A AP 2009004747A AP 2009004747 A AP2009004747 A AP 2009004747A AP 2009004747 A0 AP2009004747 A0 AP 2009004747A0
Authority
AP
ARIPO
Prior art keywords
ethoionamide
activity
compounds
potentiating effect
potentiating
Prior art date
Application number
AP2009004747A
Other languages
English (en)
Inventor
Nicolas Willand
Benoit Deprez
Bertrand Dirie
Original Assignee
Inst Pasteur De Lille Ct Nat D
Univ Lille
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Pasteur De Lille Ct Nat D, Univ Lille filed Critical Inst Pasteur De Lille Ct Nat D
Publication of AP2009004747A0 publication Critical patent/AP2009004747A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/472—Non-condensed isoquinolines, e.g. papaverine
    • A61K31/4725—Non-condensed isoquinolines, e.g. papaverine containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/08—Antibacterial agents for leprosy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AP2009004747A 2006-07-04 2007-07-04 Compounds having a potentiating effect on the activity of ethoionamide and uses thereof AP2009004747A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0606088A FR2903405B1 (fr) 2006-07-04 2006-07-04 Composes a effet potentialisateur de l'activite de l'ethionamide et leurs applications
PCT/FR2007/001138 WO2008003861A1 (fr) 2006-07-04 2007-07-04 Composes a effet potentialisateur de l'activite de l'ethionamide et leurs applications

Publications (1)

Publication Number Publication Date
AP2009004747A0 true AP2009004747A0 (en) 2009-02-28

Family

ID=37775154

Family Applications (1)

Application Number Title Priority Date Filing Date
AP2009004747A AP2009004747A0 (en) 2006-07-04 2007-07-04 Compounds having a potentiating effect on the activity of ethoionamide and uses thereof

Country Status (13)

Country Link
US (1) US8338599B2 (fr)
EP (1) EP2044064A1 (fr)
JP (1) JP2009541474A (fr)
KR (1) KR20090043506A (fr)
CN (1) CN101516876A (fr)
AP (1) AP2009004747A0 (fr)
AU (1) AU2007271013A1 (fr)
BR (1) BRPI0714225A2 (fr)
CA (1) CA2656502C (fr)
EA (1) EA200970081A1 (fr)
FR (1) FR2903405B1 (fr)
WO (1) WO2008003861A1 (fr)
ZA (1) ZA200810703B (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009080432A2 (fr) 2007-12-21 2009-07-02 Eth Zurich Composition destinée au traitement de la tuberculose
GB0813740D0 (en) * 2008-07-28 2008-09-03 Angeletti P Ist Richerche Biologica Therapeutic compounds
JP5685247B2 (ja) * 2009-06-25 2015-03-18 バイオヴァーシス・アーゲーＢｉｏｖｅｒｓｙｓ Ａｇ 結核を処置するための組成物
GB0916608D0 (en) * 2009-09-22 2009-11-04 Angeletti P Ist Richerche Bio Therapeutic compounds
WO2012040170A2 (fr) * 2010-09-20 2012-03-29 University Of Virginia Patent Foundation Compositions et méthodes de traitement de la tuberculose
US8962658B2 (en) 2011-10-25 2015-02-24 Universite De Droit Et De La Sante De Lille 2 Fluoralkylcarbonyl-oxadiazoles
EP2809668B1 (fr) 2012-02-02 2017-04-12 Actelion Pharmaceuticals Ltd. Composés de 4-(benzoimidazol-2-yle)-thiazole et dérivés aza associés
FR3000064A1 (fr) 2012-12-21 2014-06-27 Univ Lille Ii Droit & Sante Composes de type spiroisoxazoline ayant une activite potentialisatrice de l'activite d'un antibiotique-composition et produit pharmaceutiques comprenant de tels composes
FR3000065A1 (fr) 2012-12-21 2014-06-27 Univ Lille Ii Droit & Sante Composes bicycliques ayant une activite potentialisatrice de l'activite d'un antibiotique actif contre les mycobacteries-composition et produit pharmaceutiques comprenant de tels composes
ES2671323T3 (es) 2013-07-22 2018-06-06 Idorsia Pharmaceuticals Ltd Derivados 1¿(piperazin¿1¿il)¿2¿([1,2,4]triazol¿1¿il)¿etanona
AR099789A1 (es) 2014-03-24 2016-08-17 Actelion Pharmaceuticals Ltd Derivados de 8-(piperazin-1-il)-1,2,3,4-tetrahidro-isoquinolina
AR103399A1 (es) 2015-01-15 2017-05-10 Actelion Pharmaceuticals Ltd Derivados de (r)-2-metil-piperazina como moduladores del receptor cxcr3
HRP20190024T1 (hr) 2015-01-15 2019-02-22 Idorsia Pharmaceuticals Ltd Derivati hidroksialkil-piperazina kao modulatori receptora cxcr3
HRP20211894T1 (hr) * 2017-08-16 2022-08-19 Glaxosmithkline Intellectual Property Development Limited Novi spojevi
US20200281202A1 (en) * 2017-09-08 2020-09-10 Pi Industries Ltd. Novel fungicidal heterocyclic compounds
CN108558858A (zh) * 2018-05-23 2018-09-21 成都师范学院 硝基呋喃类抗结核化合物
WO2020113094A1 (fr) 2018-11-30 2020-06-04 Nuvation Bio Inc. Composés pyrrole et pyrazole et leurs procédés d'utilisation
CN116438174B (zh) * 2020-06-23 2025-10-31 南京艾美斐生物医药科技有限公司 化合物及其作为mif抑制剂的用途

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2275458A1 (fr) * 1974-06-21 1976-01-16 Aries Robert Analogues de la rifampicine portant un noyau oxadiazole
US6107313A (en) * 1998-10-02 2000-08-22 Combichem, Inc. Dopamine receptor antagonists
WO2001002375A1 (fr) * 1999-07-01 2001-01-11 Chemrx Advanced Technologies, Inc. Synthese d'oxadiazoles
US20010049373A1 (en) * 2000-01-28 2001-12-06 Chalquest Richard R. Materials and methods for killing nematodes and nematode eggs
WO2003093297A2 (fr) * 2002-05-03 2003-11-13 Exelixis, Inc. Modulateurs de proteine kinase et procedes d'utilisation
JP2006502134A (ja) * 2002-08-09 2006-01-19 アストラゼネカ アクチボラグ 代謝調節型グルタミン酸受容体において活性を有する化合物
GB0325956D0 (en) * 2003-11-06 2003-12-10 Addex Pharmaceuticals Sa Novel compounds
JP4958560B2 (ja) * 2003-12-24 2012-06-20 プロシディオン・リミテッド Ｇｐｃｒ受容体作動薬としてのヘテロ環誘導体
EP1604989A1 (fr) * 2004-06-08 2005-12-14 Santhera Pharmaceuticals (Deutschland) Aktiengesellschaft Inhibiteurs de DPP-IV
AU2005290081B2 (en) * 2004-08-23 2010-12-02 Merck Sharp & Dohme Corp. Inhibitors of Akt activity
TW200633990A (en) * 2004-11-18 2006-10-01 Takeda Pharmaceuticals Co Amide compound
TW200635587A (en) * 2004-12-01 2006-10-16 Kalypsys Inc Inducible nitric oxide synthase dimerization inhibitors
AU2005316826A1 (en) * 2004-12-15 2006-06-22 Merck Sharp & Dohme Corp. Inhibitors of Akt activity
US8193359B2 (en) * 2004-12-24 2012-06-05 Prosidion Limited G-protein coupled receptor agonists

Also Published As

Publication number Publication date
ZA200810703B (en) 2009-10-28
JP2009541474A (ja) 2009-11-26
US8338599B2 (en) 2012-12-25
US20110136823A1 (en) 2011-06-09
CA2656502C (fr) 2017-06-13
FR2903405B1 (fr) 2011-09-09
CN101516876A (zh) 2009-08-26
WO2008003861A1 (fr) 2008-01-10
KR20090043506A (ko) 2009-05-06
AU2007271013A1 (en) 2008-01-10
EP2044064A1 (fr) 2009-04-08
FR2903405A1 (fr) 2008-01-11
BRPI0714225A2 (pt) 2013-01-29
CA2656502A1 (fr) 2008-01-10
EA200970081A1 (ru) 2009-06-30

Similar Documents

Publication Publication Date Title
AP2009004747A0 (en) Compounds having a potentiating effect on the activity of ethoionamide and uses thereof
IL244442B (en) Compounds of converted acylanilides and their use
TWI318103B (en) Fastener
IL198301A0 (en) Thiazole and oxazole-substituted arylamides
ZA200902189B (en) Phenylpropionamide compounds and the use thereof
IL181392A0 (en) Fastener
ZA200710817B (en) Benzamide derivatives and uses related thereto
IL198046A (en) Metastatin derivatives and drugs that include them
ZA200903401B (en) The uses of the carboxy-amido-triazole compounds and salts thereof
PT2853293T (pt) Compostos de tionínio e a sua utilização
IL197714A0 (en) 2-pyridinecarboxamide derivative having gk-activating activity
IL201402A (en) A pyrimidine compound with a dibenzylamine formulation and a drug containing it
EP2028100A4 (fr) Attache
EP2077262A4 (fr) Dérivé de l'iminopyridine et son utilisation
EP2124908A4 (fr) Composés et utilisations de ceux-ci
GB0611115D0 (en) Compounds and their use
EP2099459A4 (fr) Composés et leurs utilisations
IL197074A0 (en) Thiadiazole compound and use thereof
GB0715106D0 (en) Fastener
ZA200710899B (en) Diaper fastener
EP2120957A4 (fr) Composés et leurs utilisations
AU2013206191B2 (en) Thioninium compounds and their use
GB0615557D0 (en) Compounds and Uses Thereof
AU2006906752A0 (en) Pyrimidinobenzimidazole compounds and analogues thereof
GB0610888D0 (en) Compounds and their use